1
Por Berg-Johnsen, Jon, Ilstad, Eivind, Kolstad, Frode, Züchner, Mark, Sundseth, Jarle
Publicado em 2014
“... a ventral defect in the dura, is a rarely encountered cause of thoracic myelopathy. The purpose...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Khoudigian-Sinani, Shoghag, Kowal, Stacey, Suggett, Jason A, Coppolo, Dominic P
Publicado no Int J Chron Obstruct Pulmon Dis (2017)
“... were modeled using a one-year Markov model with monthly cycles and three health states: (i...”Publicado no Int J Chron Obstruct Pulmon Dis (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Leinwand, Kristina L., Gerich, Mark E., Hoffenberg, Edward J., Collins, Colm B.
Publicado no Inflamm Bowel Dis (2017)
“... of how targeting the endocannabinoid system, including cannabinoid receptors 1 and 2, endogenous...”Publicado no Inflamm Bowel Dis (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
“... that this drives chronic immune activation in HIV-1 and SIV infection. While combined antiretroviral therapy (c...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Daniele, S, Zappelli, E, Natali, L, Martini, C, Trincavelli, M L
Publicado no Cell Death Dis (2014)
“..., are as follows: (i) by A(2B)AR potentiating the pro-apoptotic effects of TMZ and (ii) by A(1)AR driving cells...”Publicado no Cell Death Dis (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
“... the knowledge of the intricacies of the systemic and the local T-cell activity. SUMMARY: Depending...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
“... interrelationship with TNF and IL‐1, currently the most targeted cytokines in the treatment of RA. IL‐17 is involved...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Abla, Nada, Keiser, Jennifer, Vargas, Mireille, Reimers, Natalie, Haas, Helmut, Spangenberg, Thomas
Publicado no PLoS Negl Trop Dis (2017)
“... in the Schistosoma mansoni mouse model to determine the key factors that drive its efficacy. Dose-response studies...”Publicado no PLoS Negl Trop Dis (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Assuntos:
“...Case Study...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Galluzzi, L, Vitale, I, Michels, J, Brenner, C, Szabadkai, G, Harel-Bellan, A, Castedo, M, Kroemer, G
Publicado em 2014
“...The platinum derivative cis-diamminedichloroplatinum(II), best known as cisplatin, is currently...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Kassis, Timothy, Skelton, Henry M., Lu, Iris M., Moorhead, Andrew R., Dixon, J. Brandon
Publicado no PLoS Negl Trop Dis (2014)
“..., including B. malayi, which migrate to the human lymphatic system following transmission. The parasites...”Publicado no PLoS Negl Trop Dis (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Brothers, Holly M., Bardou, Isabelle, Hopp, Sarah C., Marchalant, Yannick, Kaercher, Roxanne M., Turner, Sarah M., Mitchem, Mollie R., Kigerl, Kristina, Wenk, Gary L.
Publicado em 2013
“... is sufficient to drive, but not sustain, spatial memory impairment and a decrease in tyrosine hydroxylase...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
“... on predicting EID occurrence to “get ahead of the curve” – that is, allowing health systems to be poised...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Kostecka, A, Sznarkowska, A, Meller, K, Acedo, P, Shi, Y, Mohammad Sakil, H A, Kawiak, A, Lion, M, Królicka, A, Wilhelm, M, Inga, A, Zawacka-Pankau, J
Publicado no Cell Death Dis (2014)
“... current anti-cancer therapies. Additionally, in ROS-compromised cancer cells ubiquitin proteasome system...”Publicado no Cell Death Dis (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
“... to be $ 44 million (Rs 2,350 million), $23 million (Rs 1,230 million) and $ 11 million (Rs 590 million...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Germain, Dominique P
Publicado em 2010
“... annual incidence of 1 in 100,000 may underestimate the true prevalence of the disease. Classically...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Khan, MS., Khine, TM., Hutchison, C., Coker, RJ., Hane, KM., Innes, AL., Aung, S.
Publicado no BMC Infect Dis (2016)
“... potential health systems barriers that may be driving lower tuberculosis case finding among women. METHODS...”Publicado no BMC Infect Dis (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18